Why the study?
Does IL-10 play a critical role in the induction of nasal tolerance and suppression of experimental autoimmune myocarditis?
Does IL-10 play a critical role in the induction of nasal tolerance and suppression of experimental autoimmune myocarditis?
IL-10 is critical for the induction of nasal tolerance and limits inflammation during the effector phase of experimental autoimmune myocarditis.
Answers are grounded in this paper and cite their sources.
IL-10 dependence of nasal tolerance in myocarditis models; extends preclinical mechanisms but leaves open human translation.
Appropriate treatment of autoimmune myocarditis following virus infection remains a major clinical problem. Induction of nasal tolerance may provide a new approach to treatment. However, the exact mechanism of nasal tolerance is unknown. To assess the mechanism of nasal tolerance, we examined the role of IL-10 in the induction and suppression of autoimmune myocarditis. First we showed that blocking IL-10 concurrent with nasal administration of Ag abolished the disease-suppressing effect of nasal tolerization. It also led to increased cardiac myosin-specific IL-1 and TNF-alpha production. Then we demonstrated that blocking IL-10 during the effector phase increased not only the incidence and severity of disease but also Ag-specific IL-2, IL-4, and TNF-alpha production as well as cardiac myosin-specific IgG1 and IgG2b production, whereas blocking IL-10 during the induction phase had no effect. This study implicates IL-10 in the induction of nasal tolerance and in limiting inflammation later during the disease process.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: